Interactive Investor
>>

Tiziana Life Sciences Ltd Ordinary Shares (NASDAQ:TLSA) Share Price

TLSA

Tiziana Life Sciences Ltd Ordinary Shares

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its clinical pipeline includes drug assets for Crohn's Disease, COVID19, Secondary Progressive Multiple Sclerosis, and Hepatocellular Carcinoma. Its development pipeline includes Foralumab, Milciclib, Anti-IL6R, and Others. The company has a single reporting segment, which is the research and development of biotechnological & pharmaceutical products.Tiziana Life Sciences PLC develops novel molecules that impact serious human diseases in oncology and immunology. It is focused on developing next-generation therapeutics and diagnostics for cancers and immune diseases.

NASDAQ:TLSA

BMG889121031

USD

Loading...

Loading Comparison

Latest TLSA News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News